Excludes commercial-in-confidence projects.
Research since 2008 is shown below.
Open access indicates that an output is open access.
Broughton, SE, Hercus, TR, Nero, TL, Kan, WL, Barry, EF, Dottore, M, Cheung Tung Shing, KS, Morton, CJ, Dhagat, U, Hardy, MP, Wilson, NJ, Downton, MT, Schieber, C, Hughes, TP, Lopez, AF & Parker, MW 2018, 'A dual role for the N-terminal domain of the IL-3 receptor in cell signalling', Nature Communications, vol. 9, no. 1, article no. 386, pp. 1-15.
Open access 12 12 5
Tvorogov, D, Thomas, D, Liau, NP, Dottore, M, Barry, EF, Lathi, M, Kan, WL, Hercus, TR, Stomski, F, Hughes, TP, Tergaonkar, V, Parker, MW, Ross, DM, Majeti, R, Babon, JJ & Lopez, AF 2018, 'Accumulation of JAK activation loop phosphorylation is linked to type I JAK inhibitor withdrawal syndrome in myelofibrosis', Science Advances, vol. 4, no. 11, article no. eaat3834, pp. 1-13.
Open access 9 9 1
Wittwer, NL, Brumatti, G, Marchant, C, Sandow, JJ, Pudney, MK, Dottore, M, D'Andrea, RJ, Lopez, AF, Ekert, PG & Ramshaw, HS 2017, 'High CD123 levels enhance proliferation in response to IL-3, but reduce chemotaxis by downregulating CXCR4 expression', Blood Advances, vol. 1, no. 15, pp. 1067-1079.
Open access 7 7 1
External engagement & recognition
|Murdoch Childrens Research Institute||AUSTRALIA|
|South Australian Health and Medical Research Institute (SAHMRI)||AUSTRALIA|
|St. Vincent's Institute of Medical Research||AUSTRALIA|
|Stanford University||UNITED STATES|
|University of Melbourne||AUSTRALIA|
|University of South Australia||AUSTRALIA|
|Walter and Eliza Hall Institute of Medical Research||AUSTRALIA|